Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Jida Guo,Shengqiang Zhang,Jun Wang,Pengfei Zhang,Tong Lu,Linyou Zhang

DOI: https://doi.org/10.3389/fonc.2022.970020

IF: 4.7

2022-07-05

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.833719.].

oncology

What problem does this paper attempt to address?

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Xiaozhong Liao,Ying Gao,Jiahui Liu,Lan-Ting Tao,Dongmei Wang,Dan Xie,Sui‐Lin Mo

DOI: https://doi.org/10.3389/fonc.2021.670798

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.01756/full.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Huan Shi,Xin-Yu LI,Yao Chen,Xing Zhang,Yong Wu,Zi-Xuan Wang,Pan-Hong Chen,Hui-Qi Dai,Ji Feng,Sayantan Chatterjee,Zhong-Jie Li,Xiao-Wei Huang,Hong-Qiao Wei,Jigang Wang,Guo-Dong Lu,Jing Zhou

DOI: https://doi.org/10.3389/fphar.2020.640750

IF: 5.6

2021-02-08

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.534171.].

pharmacology & pharmacy
Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Dongli Yue,Daiqun Zhang,Xiaojuan Shi,Shasha Liu,Anqi Li,Dong Wang,Guohui Qin,Yu Ping,Yamin Qiao,Xinfeng Chen,Feng Wang,Renyin Chen,Song Zhao,Lidong Wang,Yi Zhang

DOI: https://doi.org/10.3389/fonc.2022.860158

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00311.].

oncology
Corrigendum: Anlotinib Combined with Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Jingzhen Shi,Ying-jie Zhang,Jin-zhi Wang,Jianbin Li,Zhenxiang Li

DOI: https://doi.org/10.3389/fonc.2020.583499

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00995.].
Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Xu Zhang,Jie Wang,Yifeng Wang,Guanzheng Liu,Huan Li,Jiefeng Yu,Runqiu Wu,Jun Liang,Rutong Yu,Xuejiao Liu

DOI: https://doi.org/10.3389/fonc.2022.911817

IF: 4.7

2022-04-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.608082.].

oncology
Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway

Yue Wang,Ying Li,Liang Wang,Buze Chen,Miaolin Zhu,Chunyi Ma,Chunyan Mu,Aibin Tao,Shibao Li,Lan Luo,Ping Ma,Shuai Ji,Ting Lan

DOI: https://doi.org/10.3389/fphar.2024.1427330

2024-07-08

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.779608.].
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei,Juanjuan Shi,Qianhan Lin,Xiaoxue Ma,Yingxin Pang,Hongluan Mao,Rui Li,Wei Lu,Yu Wang,Peishu Liu

DOI: https://doi.org/10.3389/fonc.2021.742374

IF: 4.7

2021-09-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.642229.].

oncology
Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Kaiming Zhang,Peng Liu,Hailin Tang,Xiaoming Xie,Yanan Kong,Cailu Song,Xingsheng Qiu,Xiangsheng Xiao

DOI: https://doi.org/10.3389/fphar.2020.01107

IF: 5.6

2020-07-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2018.01248.].

pharmacology & pharmacy
Corrigendum: GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT

En Xu,Xuefeng Xia,Chaoyu Jiang,Zijian Li,Zhi Yang,Chang Zheng,Xingzhou Wang,Shangce Du,Ji Miao,Feng Wang,Yizhou Wang,Xiaofeng Lu,Wenxian Guan

DOI: https://doi.org/10.3389/fcell.2022.841792

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.591239.].
Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Yongmeng Li,Yanfei Liu,Kai Jin,Rui Dong,Cun Gao,Libo Si,Zitong Feng,Huiying Zhang,Hui Tian

DOI: https://doi.org/10.3389/fcell.2022.870313

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.771824.].
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].
Corrigendum: Anticancer applications of phytochemicals in gastric cancer: effects and molecular mechanism

Zhaofeng Liang,Yumeng Xu,Yue Zhang,Xinyi Zhang,Jiajia Song,Hui Qian,Jianhua Jin

DOI: https://doi.org/10.3389/fphar.2024.1405513

2024-08-19

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1078090.].
Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2022.1008088

IF: 5.5

2022-09-23

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00840.].

cell biology,developmental biology
Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling

Neng Wang,Gulizeba Muhetaer,Xiaotong Zhang,Bowen Yang,Caiwei Wang,Yu Zhang,Xuan Wang,Juping Zhang,Shengqi Wang,Yifeng Zheng,Fengxue Zhang,Zhiyu Wang

DOI: https://doi.org/10.3389/fphar.2021.810621

IF: 5.6

2022-01-06

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.591400.].

pharmacology & pharmacy
Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Tianyu Zhai,Xiaoyu Zhang,Zhenyu Hei,Longyang Jin,Chao Han,Audrey Tsznam Ko,Xiaofeng Yu,Jiandong Wang

DOI: https://doi.org/10.3389/fphar.2021.792330

IF: 5.6

2021-10-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.628621.].

pharmacology & pharmacy
Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Huijuan Liu,Honglian Tao,Hongqi Wang,Yuyan Yang,Ru Yang,Xintong Dai,Xiujuan Ding,Haidong Wu,Shuang Chen,Tao Sun

DOI: https://doi.org/10.3389/fonc.2022.830506

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.619317.].

oncology
Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Yun-Zhu Zeng,Yong-Qu Zhang,Jiong-Yu Chen,Li-Ying Zhang,Wen-Liang Gao,Xue-Qiong Lin,Shao-Min Huang,Fan Zhang,Xiao-Long Wei

DOI: https://doi.org/10.3389/fonc.2021.767805

IF: 4.7

2021-10-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.627713.].

oncology
Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Xiu-Ying He,Yang Xu,Qing-Jie Xia,Xiao-Ming Zhao,Shan Li,Xiao-Qiong He,Ru-Rong Wang,Ting-Hua Wang

DOI: https://doi.org/10.3389/fonc.2022.872110

IF: 4.7

2022-03-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.663262.].

oncology
Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters

Mengjun Zhang,Haodi Yue,Yuan Liu,Hao Li,Yue Yin,Zhenxing Sun,Ping Cui,Fei Li,Xiuwei Chen,Xin Huang

DOI: https://doi.org/10.3389/fonc.2022.983959

IF: 4.7

2022-07-20

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.898917.].

oncology

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Corrigendum: Anlotinib Combined with Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Corrigendum: GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT

Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum: Anticancer applications of phytochemicals in gastric cancer: effects and molecular mechanism

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters